Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain
Background: In young women, combined hormonal contraceptives can ameliorate menstrual pain and reduce menstrual loss, but their efficacy in adenomyosis has not been proven. The aim of this study was to investigate whether ultrasound features of adenomyosis are modified by a combined hormonal contrac...
Saved in:
Main Authors: | Anjeza Xholli (Author), Anna Biasioli (Author), Giovanni Grandi (Author), Angelo Cagnacci (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 and hormonal contraception
by: Angelo Cagnacci, et al.
Published: (2022) -
Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
by: Rafie S, et al.
Published: (2013) -
Information on the combined hormonal contraceptives (CHC) containing the dienogest + ethinyl estradiol combination (Jeanine®)
by: A. D. Makatsariya, et al.
Published: (2019) -
Breast cancer and the steadily increasing maternal age: are they colliding?
by: Ambrogio P. Londero, et al.
Published: (2024) -
Gut Microbiota and Endometriosis: Exploring the Relationship and Therapeutic Implications
by: Anjeza Xholli, et al.
Published: (2023)